维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Anna Bajor"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion显示文摘AIM: To evaluate the association between the size of peripheral retinal non-perfusion and the number of intravitreal ranibizumab injections in patients with treatment-naive branch retinal vein occlusion(BRVO)and macular edema.METHODS: A total of 53 patients with treatment-naive BRVO and macular edema were included. Each patient underwent a full ophthalmologic examination including optical coherence tomography(OCT) imaging and ultra wide-field fluorescein angiography(UWFA). Monthly intravitreal ranibizumab injections were applied according to the recommendations of the German Ophthalmological Society. Two independent, masked graders quantified the areas of peripheral retinal non-perfusion. RESULTS: Intravitreal injections improved best-corrected visual acuity(BCVA) significantly from 22.23 ±16.33 Early Treatment of Diabetic Retinopathy Study(ETDRS) letters to 36.23 ±15.19 letters(P <0.001), and mean central subfield thickness significantly reduced from 387±115 μm to 321±115 μm(P =0.01). Mean number of intravitreal ranibizumab injections was 3.61 ±1.56. The size of retinal non-perfusion correlated significantly with the number of intravitreal ranibizumab injections(R =0.724, P <0.001). CONCLUSION: Peripheral retinal non-perfusion in patients with BRVO associates significantly with intravitreal ranibizumab injections in patients with BRVO and macular edema.	Kaveh Abri Aghdam Lukas Reznicek Mostafa Soltan Sanjari Carsten Framme Anna Bajor Annemarie Klingenstein Marcus Kernt Florian Seidensticker	2016	International Journal of Ophthalmology(English edition)2016，9，6：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费